Katherine Hoadley

Assistant Professor

University of North Carolina at Chapel Hill

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (14)

Mustapha Abubakar

National Institutes of Health

UNITED STATES

View details

Sherene Loi

University of Melbourne

AUSTRALIA

View details

Charles Perou

Professor

University of North Carolina

UNITED STATES

View details

Terry Hyslop

Professor, Director of SKCC Center for Health Equity

Thomas Jefferson University

UNITED STATES

View details

Aranzazu Fernandez-Martinez

University of North Carolina, Lineberger Comprehensive Cancer Center

UNITED STATES

View details

David Foran

Professpr/CIO/Dir. Imaging & Informatics

Rutgers Cancer Institute of New Jersey

UNITED STATES

View details

Benjamin Calhoun

Associate Professor

University of North Carolina

UNITED STATES

View details

Michael Love

Associate Professor

University of North Carolina at Chapel Hill

UNITED STATES

View details

Sarah Van Alsten

University of North Carolina at Chapel Hill

UNITED STATES

View details

David Wedge

The University of Manchester

UNITED KINGDOM

View details

Olufunmilayo I. Olopade

University of Chicago

UNITED STATES

View details

Richard Moffitt

Associate Professor

Emory University

UNITED STATES

View details

Xiaohua Gao

University of North Carolina

UNITED STATES

View details

Yuki Saito

National Cancer Center Research Institute

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Katherine Hoadley

Research Interests

Explore related searches

Contact this professor

Articles (10)

Incorporating RNA-based Risk Scores for Genomic Instability to Predict Breast Cancer Recurrence and Immunogenicity in a Diverse Population

Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer Reveals TP53 Aneuploidy–driven Metabolic Reprogramming

Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727)

Spatial Characterization of Tumor-Infiltrating Lymphocytes and Breast Cancer Progression

CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer

TP53 Pathway Function, Estrogen Receptor Status, and Breast Cancer Risk Factors in the Carolina Breast Cancer Study

Race and Ancestry in Immune Response to Breast Cancer

DNA Damage Repair Classifier Defines Distinct Groups in Hepatocellular Carcinoma

Prognostic significance of RNA-based TP53 pathway function among estrogen receptor positive and negative breast cancer cases

Genomic characterization of rare molecular subclasses of hepatocellular carcinoma

Collaborators (14)

Mustapha Abubakar

Sherene Loi

Charles Perou

Terry Hyslop

Aranzazu Fernandez-Martinez

David Foran

Benjamin Calhoun

Michael Love

Sarah Van Alsten

David Wedge

Olufunmilayo I. Olopade

Richard Moffitt

Xiaohua Gao

Yuki Saito

Make your next move.